Use of phosphate binders in end-stage renal disease: An experience from a secondary care hospital in United Arab Emirates
Objective: Hyperphosphatemia in end-stage renal disease (ESRD) is associated with many serious patient-level consequences including cardiovascular events and mortality. The purpose of this study was to investigate the use of phosphate binders in ESRD patients on maintenance hemodialysis. Materials a...
Main Authors: | Syed Arman Rabbani, Sathvik B Sridhar, Padma G M Rao, Martin T Kurian, Basset E Essawy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Journal of Pharmacy and Bioallied Sciences |
Subjects: | |
Online Access: | http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2019;volume=11;issue=2;spage=148;epage=154;aulast=Rabbani |
Similar Items
-
Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial
by: Eunsoo Lim, et al.
Published: (2018-03-01) -
How to assess the efficacy of phosphate binders
by: Francisco Caravaca, et al.
Published: (2017-05-01) -
Interventional study to improve adherence to phosphate binder treatment in dialysis patients
by: Bodil Jahren Hjemås, et al.
Published: (2019-05-01) -
Phosphate binders in chronic kidney disease: The positions of sevelamer
by: V V Fomin, et al.
Published: (2013-06-01) -
Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study
by: Kamyar Kalantar-Zadeh, et al.
Published: (2019-10-01)